Effects of COVID-19 on preclinical and clinical research in neurology: Examples from research on neurodegeneration and Alzheimer’s disease

Effects of COVID-19 on preclinical and clinical research in neurology: Examples from research on neurodegeneration and Alzheimer’s disease

The COVID-19 pandemic has had a profound impact on neuroscientists, including those involved in translational research. In this NeuroView, we discuss the positive and negative effects of the pandemic on preclinical research and clinical studies in humans. The COVID-19 pandemic has had a profound imp...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuron (Cambridge, Mass.) Mass.), 2021-10, Vol.109 (20), p.3199-3202
Hauptverfasser: Snider, B. Joy, Holtzman, David M.
Format: Artikel
Sprache:eng
Schlagworte:
Alzheimer’s disease
clinical trials
COVID-19
translational neuroscience
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The COVID-19 pandemic has had a profound impact on neuroscientists, including those involved in translational research. In this NeuroView, we discuss the positive and negative effects of the pandemic on preclinical research and clinical studies in humans. The COVID-19 pandemic has had a profound impact on neuroscientists, including those involved in translational research. In this NeuroView, Snider and Holtzman discuss the positive and negative effects of the pandemic on preclinical research and clinical studies in humans.
ISSN:0896-6273
1097-4199
DOI:10.1016/j.neuron.2021.08.026